Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Sande

2 clinical trials in Sande, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Sande at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Sande

Open in trial search

Ischaemic stroke

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Insel Gruppe AG

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dnth103
  • Sponsor:Dianthus Therapeutics Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Sande

What the registry says about research in the country

01 Sande
Immune System Diseases
Clinical research in Sande includes studies focused on immune system diseases, with attention on finding better ways to manage long-term inflammatory and neurologic conditions. The trials are aimed at evaluating whether new approaches can improve patient outcomes and reduce disease-related relapse. Chronic Inflammatory Demyelinating Polyneuropathy DNTH103 compared with placebo Relapse prevention and treatment effectiveness This research reflects ongoing efforts to test a new therapy for a rare neurologic immune disorder and better understand how to support people living with persistent symptoms.
Neurology and Stroke Care
Another key area of study in Sande is stroke research, especially for patients with acute ischemic stroke who have recently taken direct oral anticoagulants. The work is centered on improving emergency treatment options and functional recovery after stroke. Acute ischemic stroke Recent ingestion of direct oral anticoagulants Evaluating whether intravenous thrombolysis improves outcomes These trials are designed to clarify the best treatment strategy in urgent stroke care and help determine whether current approaches can lead to better recovery at 90 days.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.